Bimekizumab (Bimzelx; UCB Pharma) was approved by the FDA to treat psoriatic arthritis (PsA) on September 23, 2024, based on ...

UCB, a global biopharmaceutical company, announced today that a single-injection 2 mL prefilled syringe and autoinjector, each containing 320 mg of ...

Diseases of the joints are known as arthritis. The term is derived from the Greek word that means exactly that: diseases of ...

Learn about rheumatoid vasculitis, neutrophilic dermatoses, and other rheumatoid arthritis rashes, their symptoms, and when ...

Arthritis is a common condition characterized by joint pain and stiffness. It’s crucial to debunk myths about its causes, age ...

Researchers identified 3 distinct PsA phenotype clusters, emphasizing the importance of PsO severity in treatment decision making.

Topline data were announced from two phase 3 trials evaluating deucravacitinib in adults with active psoriatic arthritis.

The following is a summary of “Variability of Psoriatic Arthritis Impact of Disease questionnaire (PsAID12) thresholds in ...

Dependable recurring dividends from quality, high-yield stocks like these five are a recipe for passive income success.

A successful claim for PIP or ADP currently provides between £28.70 and £184.30 each week in additional financial support. As ...